JUMP REPORT
| Avg Daily Volume: 8,490,778 Market Cap: 123.88B Sector: Services Short Interest: 3.61 |
EARNINGS EXPECTATIONS:
THIS QTR: EPS: 1.04/share REV: 5,250/M
___________________________________________________________
LAST QTR: EPS: .56/share ACTUAL: .60/share (BEAT)
____________________________________________________________
NEXT QTR: EPS: .81/share REV: 5,560/M
______________________________________________________
FULL YR: EPS: 3.23/share REV: 20,200/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
______________________________________________________
BEAT/MISS RECORD: 69% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -11.62, 2.58, -4.6
EXPECTED JUMP MOVE: 8%
Links To Latest News and Headlines
UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue outlook, and Doximity falls sharply after its revenue forecast misses analysts’ estimates.
Netflix stock climbed to a record high as Wall Street responded positively to the streaming video leader’s advertising plan.
BMO Capital today kept a $1,200 price target and an Outperform rating on Netflix, Inc. (NFLX) stock. The bank is bullish on the outlook of the company’s advertising tier. Strong Ad-Tier Metrics and NFLX’s Upbeat Outlook After Netflix, Inc. (NFLX) noted that the number of monthly active users of its ad tier had jumped 34% […]
“The Wall Street Journal” is reporting that UnitedHealth is under criminal investigation by the DOJ for Medicare fraud. The news comes just days after the sudden departure of the company’s CEO. UnitedHealth’s stock has lost more than half its value in a month.
Here is how Netflix (NFLX) and PIGEON CORP (PGENY) have performed compared to their sector so far this year.
StockJumpers analysis and trade plans are uploaded generally 1 HOUR (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
ANALYSIS:
StockJumpers trajectory analysis reveals an initial pop up on the news, but then a sell off and the price moves down. The market reaction may be mixed and the metric being watched is new subscribers (domestic and international). Most analysts are bullish… and there is good news but overall we think it will fall by morning.
We are biased SHORT on the event.
___________________
OUR TRADE PLAN:
ENTRY: SELL end of day
STOP LOSS: NA
INITIAL PROFIT TARGET: 8%
___________________
TRADE ASSIST: NO
POST RELEASE ACTION:
[/mepr-show
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is striped down to only what it needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.